Resultados de la búsqueda 161-170 of 16778 for nivolumab

  1. Oncología (médica) - Ensayos clínicos

    Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ...

  2. Cirugía - Ensayos clínicos

    The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with melanoma ...

  3. Oncología (médica) - Ensayos clínicos

    ... nivolumab in each disease cohort, both across and within tumor biomarker subgroups. A Study to Evaluate DS-8201a Combined with Olaparib in HER2-Expressing ...

  4. Oncología (médica) - Ensayos clínicos

    Giving nivolumab with the usual chemotherapy may work better than the usual chemotherapy alone in treating patients with nasopharyngeal cancer. Numeración ...

  5. Oncología (médica) - Ensayos clínicos

    Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ...

  6. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with melanoma ...

  7. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with melanoma ...

  8. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with melanoma ...

  9. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with melanoma ...

  10. Oncología (médica) - Ensayos clínicos

    ... nivolumab in each disease cohort, both across and within tumor biomarker subgroups. A Study to Evaluate DS-8201a Combined with Olaparib in HER2-Expressing ...